StonvexLoading…
StonvexStonvexStonvexCore line items from RARE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $673.00M | $560.00M | $434.00M | $363.33M |
Operating Income | $-535.00M | $-536.00M | $-569.00M | $-648.92M |
Net Income | $-575.00M | $-569.00M | $-607.00M | $-707.42M |
EPS (Diluted) | $-5.83 | $-6.29 | $-8.25 | $-10.12 |
Total Assets | $1.53B | $1.50B | $1.49B | $1.55B |
Total Liabilities | $1.60B | $1.24B | $1.22B | $1.19B |
Cash & Equivalents | $421.00M | $174.00M | $214.00M | $132.94M |
Free Cash Flow OCF − CapEx | $-472.00M | $-421.00M | $-519.00M | $-496.59M |
Shares Outstanding | 96.60M | 92.50M | 82.32M | 70.20M |